Boston Scientific up on device approval
NEW YORK (Reuters) - Shares of Boston Scientific Corp. (BSX.N) rose before the opening bell on Tuesday after the medical device maker won approval for a new wire to be used in defibrillators and pacemakers.
Boston Scientific shares rose 2.8 percent to $16.45 in electronic composite trading after closing on Monday at $16.00 on the New York Stock Exchange.









